Comparative Pharmacology
Head-to-head clinical analysis: FERUMOXYTOL versus VENOFER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: FERUMOXYTOL versus VENOFER.
FERUMOXYTOL vs VENOFER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Ferumoxytol is an ultrasmall superparamagnetic iron oxide nanoparticle that provides a source of iron for erythropoiesis. It is phagocytosed by macrophages of the reticuloendothelial system, and iron is released intracellularly to bind to transferrin and ferritin, replenishing iron stores.
Iron replacement therapy; iron is essential for hemoglobin synthesis and oxygen transport. VENOFER (iron sucrose) provides elemental iron that binds to transferrin for transport to erythroid precursor cells.
510 mg intravenously once, followed by 510 mg intravenously 3 to 8 days later for a total cumulative dose of 1020 mg. Administer as a slow IV injection at 1 mL/min (30 mg/min) undiluted or diluted in 50-200 mL normal saline.
Adult: 5 mL (100 mg elemental iron) IV push at 1 mL/min or IV infusion over 15-30 minutes, given 1-3 times per week to a total cumulative dose based on iron deficit calculation using Ganzoni formula.
None Documented
None Documented
Terminal elimination half-life is approximately 14-21 hours in healthy adults; prolonged in patients with iron deficiency anemia (up to 30 hours) due to increased iron utilization.
5-6 hours (initial phase, redistribution); terminal half-life ~14 hours (iron clearance from plasma). Clinical context: reflects iron utilization and storage, not elimination of drug.
Ferumoxytol is eliminated primarily through the reticuloendothelial system, with the iron moiety incorporated into hemoglobin or stored as ferritin/hemosiderin. Minimal renal or biliary excretion of intact drug; <1% excreted unchanged in urine.
Primarily reticuloendothelial system; iron is incorporated into hemoglobin and stored as ferritin/hemosiderin. Minimal renal excretion (<1% unchanged). Fecal elimination negligible. Small amounts lost via desquamation, blood loss, and menstruation.
Category C
Category C
Iron Replacement
Iron Replacement